{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-004406","form_type":"8-K","ticker":"ITGR","cik":"0001114483","company_name":"Integer Holdings Corp","filed_at":"2025-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.372614+00:00","generated_at":"2026-05-18T07:08:07.773827+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Integer appoints Michael Coyle to Board; brings 40+ years medtech leadership","bullets":["Michael Coyle appointed to Integer's Board of Directors effective July 10, 2025.","Coyle most recently served as president/CEO of iRhythm Technologies; prior roles at Medtronic, St. Jude Medical, and Eli Lilly.","He will serve on Audit, Compensation & Organization, and Technology Strategy Committees.","Board size increased to 11 directors; Coyle's term runs until next annual meeting.","Coyle holds a Wharton MBA and six U.S. patents related to cardiovascular medical devices."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-004406","json":"https://secwatch.observer/filing/0001171843-25-004406.json","markdown":"https://secwatch.observer/filing/0001171843-25-004406.md","text":"https://secwatch.observer/filing/0001171843-25-004406.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1114483/000117184325004406/0001171843-25-004406-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1114483/000117184325004406/f8k_071025.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T07:08:07.773827+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}